DNA-based vaccine clears nearly half of precancerous cervical lesions in clinical trial

Posted · Add Comment
scidaily-logo-rss

Using a novel synthetic platform for creating vaccines a team of researchers has successfully eradicated precancerous cervical lesions in nearly half of the women who received an investigational vaccine in a clinical trial.

This full article appears on <a href="http://www.sciencedaily.com/releases/2015/09/150930140619.htm">Science Daily</a>

Leave a Reply

Your email address will not be published. Required fields are marked *